AC IMMUNE SA (ACIU) Financial Statements
AC IMMUNE SA (ACIU) files with the U.S. Securities and Exchange Commission under CIK 0001651625. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- 3.57 million CHF
- Net Income
- -70.45 million CHF
- Total Assets
- 154.25 million CHF
- Net Cash from Operations
- -69.26 million CHF
Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Mar 13, 2026. Source: SEC filings (EDGAR XBRL). Amounts in CHF.
Open the full financial statements for ACIU in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History